Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. 1987

M J Zervos, and C A Kauffman, and P M Therasse, and A G Bergman, and T S Mikesell, and D R Schaberg

Enterococci with high-level resistance to gentamicin account for 55% of clinical isolates of enterococci found in patients at the Ann Arbor Veterans Administration Medical Center. We prospectively studied cultures obtained from all 100 patients hospitalized from 1 December 1985 through 23 January 1986 on the surgical and thoracic intensive care units and a general medical floor. Ten patients' cultures grew colonies of gentamicin-resistant enterococci--six after admission to the intensive care units and four after hospitalization on the medical ward. The initial sites of colonization were the rectal and perineal areas in seven patients, sternal wound in one, urine in one, and the rectal and perineal areas as well as urine after Foley catheter insertion in one. Nine patients died and three of the deaths were associated with enterococcal infection. The acquisition of resistant strains was associated with previous and more frequent exposure to antimicrobial agents, and with geographic clustering of patients. Resistant enterococci were isolated from the hands of hospital personnel and were frequently isolated from environmental surfaces. Nosocomial acquisition and interhospital spread of gentamicin-resistant enterococci was shown to have occurred when plasmid content was used as an epidemiologic marker.

UI MeSH Term Description Entries
D008297 Male Males
D008824 Michigan State bounded on the north by the Great Lakes, on the east by Canada, on the south by Wisconsin, Indiana, and Ohio, and on the west by Lake Michigan and Wisconsin.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females
D005839 Gentamicins A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS. Gentamicin Sulfate (USP),Gentamycin,G-Myticin,Garamycin,Gentacycol,Gentamicin,Gentamicin Sulfate,Gentamycins,Gentavet,Genticin,G Myticin,GMyticin,Sulfate, Gentamicin
D006748 Hospital Departments Major administrative divisions of the hospital. Departments, Hospital,Department, Hospital,Hospital Department
D006787 Hospitals, Veterans Hospitals providing medical care to veterans of wars. Veterans Hospitals,Hospital, Veterans,Veterans Hospital

Related Publications

M J Zervos, and C A Kauffman, and P M Therasse, and A G Bergman, and T S Mikesell, and D R Schaberg
June 1991, The Journal of infectious diseases,
M J Zervos, and C A Kauffman, and P M Therasse, and A G Bergman, and T S Mikesell, and D R Schaberg
May 1975, The Journal of infectious diseases,
M J Zervos, and C A Kauffman, and P M Therasse, and A G Bergman, and T S Mikesell, and D R Schaberg
December 1979, The Journal of infectious diseases,
M J Zervos, and C A Kauffman, and P M Therasse, and A G Bergman, and T S Mikesell, and D R Schaberg
October 1976, Antimicrobial agents and chemotherapy,
M J Zervos, and C A Kauffman, and P M Therasse, and A G Bergman, and T S Mikesell, and D R Schaberg
June 1985, The Journal of antimicrobial chemotherapy,
M J Zervos, and C A Kauffman, and P M Therasse, and A G Bergman, and T S Mikesell, and D R Schaberg
September 1998, Journal of clinical microbiology,
M J Zervos, and C A Kauffman, and P M Therasse, and A G Bergman, and T S Mikesell, and D R Schaberg
August 1988, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
M J Zervos, and C A Kauffman, and P M Therasse, and A G Bergman, and T S Mikesell, and D R Schaberg
May 1988, Lancet (London, England),
M J Zervos, and C A Kauffman, and P M Therasse, and A G Bergman, and T S Mikesell, and D R Schaberg
November 1973, The Journal of infectious diseases,
M J Zervos, and C A Kauffman, and P M Therasse, and A G Bergman, and T S Mikesell, and D R Schaberg
August 1974, Surgery, gynecology & obstetrics,
Copied contents to your clipboard!